Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's 40th Annual Meeting Biotech Investing
Cidara Therapeutics Announces BARDA Award to Support Expanded Manufacturing and Clinical Development of CD388, its Non-Vaccine Influenza Preventative Therapeutic Biotech Investing
LANDMARK PHASE 3 TRIAL MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS Biotech Investing
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials Biotech Investing
Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome Biotech Investing
Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference Biotech Investing
PharmaTher Provides Corporate Update on Ketamine Development and Commercial Strategy Biotech Investing
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader and Company Panel Biotech Investing
